
Sign up to save your podcasts
Or


In this episode we talk about the results of the CRASH-2 trial published in Lancet. This trial showed that the EARLY use of Tranexamic acid may improve survivial, but delayed use may be associated with an increased mortality.
By Jeffrey S. Guy, MD, FACS4.8
649649 ratings
In this episode we talk about the results of the CRASH-2 trial published in Lancet. This trial showed that the EARLY use of Tranexamic acid may improve survivial, but delayed use may be associated with an increased mortality.

64,174 Listeners

11,429 Listeners

1,079 Listeners

1,224 Listeners

941 Listeners

3,864 Listeners

2,868 Listeners

1,548 Listeners

1,146 Listeners

8,360 Listeners

406 Listeners

999 Listeners